COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study
Journal of Infection and Public Health · 2024
DOI: 10.1016/j.jiph.2024.04.005 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Álvaro Tamayo-Velasco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain; Centro de Investigación Biomédica en Re…. Hauptthemen laut MEDLINE: COVID-19, Antifungal Agents, Hematologic Neoplasms, Invasive Pulmonary Aspergillosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos…
- BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; Anesthesiology and Critical Care Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain; Department…
- Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
- BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; Microbiology Department, Hospital Universitario Rio Hortega, 47012 Valladolid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain; BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid…
- BioCritic. Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; Anesthesiology and Critical Care Department, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Tamayo-Velasco, Á., López-Herrero, R., Gómez-García, L. M., Sánchez-de Prada, L., Aguilar-Monserrate, G., Martín-Fernández, M., Bardají-Carrillo, M., Álvaro-Meca, A., Tamayo, E., Resino, S., Miramontes-González, J. P., & Peñarrubia-Ponce, M. J. (2024). COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.04.005
Vancouver
Tamayo-Velasco Á, López-Herrero R, Gómez-García LM, Sánchez-de Prada L, Aguilar-Monserrate G, Martín-Fernández M, et al. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.04.005
BibTeX
@article{TamayoVelasco2024,
author = {Tamayo-Velasco, Álvaro and López-Herrero, Rocío and Gómez-García, Lara María and Sánchez-de Prada, Laura and Aguilar-Monserrate, Gerardo and Martín-Fernández, Marta and Bardají-Carrillo, Miguel and Álvaro-Meca, Alejandro and Tamayo, Eduardo and Resino, Salvador and Miramontes-González, José Pablo and Peñarrubia-Ponce, María Jesús},
title = {COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study},
journal = {Journal of Infection and Public Health},
year = {2024},
doi = {10.1016/j.jiph.2024.04.005}
}
EUVIMED